Challenges and Advances in Managing Thrombocytopenic Cancer Patients

Cancer patients have varying incidence, depth and duration of thrombocytopenia. The mainstay of managing severe chemotherapy-induced thrombocytopenia (CIT) in cancer is the use of platelet transfusions. While prophylactic platelet transfusions reduce the bleeding rate, multiple unmet needs remain, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Leader, Avi, Hofstetter, Liron, Spectre, Galia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000983/
https://www.ncbi.nlm.nih.gov/pubmed/33799591
http://dx.doi.org/10.3390/jcm10061169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000983/
https://www.ncbi.nlm.nih.gov/pubmed/33799591
http://dx.doi.org/10.3390/jcm10061169

Ejemplares similares